2-(甲酰氨基)吡啶
|
P708889-1g
|
≥98% |
34813-97-3 |
1g
|
¥ 2483.9
|
期货,请咨询 |
阿拉丁 |
1-(4-异丙基苯基)丙-1-酮
|
P708883-250mg
|
≥95% |
27465-52-7 |
250mg
|
¥ 410.9
|
期货,请咨询 |
阿拉丁 |
1-(4-异丙基苯基)丙-1-酮
|
P708883-1g
|
≥95% |
27465-52-7 |
1g
|
¥ 1112.9
|
期货,请咨询 |
阿拉丁 |
1-(4-异丙基苯基)丙-1-酮
|
P708883-100mg
|
≥95% |
27465-52-7 |
100mg
|
¥ 244.9
|
期货,请咨询 |
阿拉丁 |
2-苯基-3-氨基丙酸甲酯
|
P708880-200mg
|
|
99092-02-1 |
200mg
|
¥ 1402.9
|
期货,请咨询 |
阿拉丁 |
26113中间体衍生物4
|
P708872-5g
|
≥97% |
439097-58-2 |
5g
|
¥ 7888.9
|
期货,请咨询 |
阿拉丁 |
26113中间体衍生物4
|
P708872-250mg
|
≥97% |
439097-58-2 |
250mg
|
¥ 656.9
|
期货,请咨询 |
阿拉丁 |
26113中间体衍生物4
|
P708872-1g
|
≥97% |
439097-58-2 |
1g
|
¥ 1970.9
|
期货,请咨询 |
阿拉丁 |
4-羟基-1,10-菲咯啉
|
P708846-5g
|
≥97% |
23443-31-4 |
5g
|
¥ 1155.9
|
期货,请咨询 |
阿拉丁 |
4-羟基-1,10-菲咯啉
|
P708846-250mg
|
≥97% |
23443-31-4 |
250mg
|
¥ 93.9
|
期货,请咨询 |
阿拉丁 |
4-羟基-1,10-菲咯啉
|
P708846-1g
|
≥97% |
23443-31-4 |
1g
|
¥ 254.9
|
期货,请咨询 |
阿拉丁 |
4-(4-氟苯氧基)哌啶
|
P708845-5g
|
≥95% |
3413-28-3 |
5g
|
¥ 3591.9
|
期货,请咨询 |
阿拉丁 |
4-(4-氟苯氧基)哌啶
|
P708845-250mg
|
≥95% |
3413-28-3 |
250mg
|
¥ 208.9
|
期货,请咨询 |
阿拉丁 |
4-(4-氟苯氧基)哌啶
|
P708845-1g
|
≥95% |
3413-28-3 |
1g
|
¥ 826.9
|
期货,请咨询 |
阿拉丁 |
4-(4-氟苯氧基)哌啶
|
P708845-100mg
|
≥95% |
3413-28-3 |
100mg
|
¥ 113.9
|
期货,请咨询 |
阿拉丁 |
4-(苯硫基)哌啶
|
P708844-250mg
|
|
101798-65-6 |
250mg
|
¥ 2145.9
|
期货,请咨询 |
阿拉丁 |
2-苯乙基吡咯烷
|
P708836-1g
|
≥95% |
106366-30-7 |
1g
|
¥ 2427.9
|
期货,请咨询 |
阿拉丁 |
2-(2-氯苯基)吡咯烷
|
P708832-100mg
|
≥95% |
129540-21-2 |
100mg
|
¥ 578.9
|
期货,请咨询 |
阿拉丁 |
吡啶-2-基甲磺酰氯
|
P708828-250mg
|
≥95% |
540523-41-9 |
250mg
|
¥ 2860.9
|
期货,请咨询 |
阿拉丁 |
吡啶-2-基甲磺酰氯
|
P708828-1g
|
≥95% |
540523-41-9 |
1g
|
¥ 5532.9
|
期货,请咨询 |
阿拉丁 |
1-(2,3-二氢苯并[b][1,4]二氧杂环己烯-6-基)丙-1-酮
|
P708824-5g
|
≥95% |
20632-12-6 |
5g
|
¥ 884.9
|
期货,请咨询 |
阿拉丁 |
1-(2,3-二氢苯并[b][1,4]二氧杂环己烯-6-基)丙-1-酮
|
P708824-250mg
|
≥95% |
20632-12-6 |
250mg
|
¥ 54.9
|
期货,请咨询 |
阿拉丁 |
1-(2,3-二氢苯并[b][1,4]二氧杂环己烯-6-基)丙-1-酮
|
P708824-1g
|
≥95% |
20632-12-6 |
1g
|
¥ 188.9
|
期货,请咨询 |
阿拉丁 |
1-(2,3-二氢苯并[b][1,4]二氧杂环己烯-6-基)丙-1-酮
|
P708824-100mg
|
≥95% |
20632-12-6 |
100mg
|
¥ 39.9
|
期货,请咨询 |
阿拉丁 |